Table of Contents

Wegovy is a popular weight-loss medicine whose active ingredient is semaglutide. Until recently, Wegovy was only available as a weekly injection under the skin. Now, a new Wegovy pill offers the same medicine in a daily oral form. Both versions work on the same hormone system, the GLP-1 system, to reduce appetite and help people lose weight. The big question is whether the pill works as well as the shot.

In this article, we’ll look at the evidence from recent clinical studies and expert sources to explain whether the new Wegovy pill is as effective for weight loss as the original injection.

Key Takeaways

  • Wegovy pills and injections deliver nearly the same weight loss when taken correctly, with average reductions ranging from 14 to 15% of body weight over about one year.
  • The active drug is identical in both forms, so once semaglutide reaches the bloodstream, it affects appetite, fullness, and blood sugar regulation in the same way regardless of whether it came from a pill or a shot.
  • Lower absorption does not make the pill weaker, because the daily 25 mg oral dose is designed to compensate for the fact that only about 1 to 2% is absorbed through the gut.
  • The biggest practical difference between a pill and an injection is routine, since injections require a weekly habit while pills require a precise daily morning schedule.

What is Wegovy and how does it work?

GLP-1 is a hormone released by the intestines after eating. It tells the brain when you’re full and slows stomach emptying, so you feel full for a longer time after eating. GLP-1 also boosts insulin secretion, which lowers blood sugar.

Semaglutide, which is the active ingredient in Wegovy, mimics GLP-1 and tricks the body into thinking it has eaten enough. The result is that hunger goes down, cravings decrease, and blood glucose spikes after meals are blunted. In effect, both forms of Wegovy make it easier for people to eat less without feeling deprived, which leads to weight loss over time.

Both the injection and the pill contain the same active drug and work in this same way once they enter the body. The main difference is how the drug gets into the bloodstream. The injection delivers semaglutide directly under the skin (subcutaneously), which leads to almost all of the dose entering the blood.

In contrast, the pill must travel through the digestive system, and only a tiny fraction, approximately 1% to 2% of the oral dose, actually enters the bloodstream. To compensate for this low absorption, the Wegovy pill is taken every day and at a higher dose (25 mg) to build up enough medication in the body.

Previously, oral semaglutide was only approved for type 2 diabetes, under the brand name Rybelsus, in doses up to 14 mg, and those tablets also caused some weight loss. But the new Wegovy pill is specifically approved for weight loss and comes in a higher 25 mg dose. It is designed to have a much stronger effect on weight than earlier oral versions of the drug.

GLP-1 medications like Wegovy have marked a major step forward in obesity treatment. They are much more effective for weight loss than older diet drugs. But some people prefer pills over injections, so having both forms available gives patients more choices.

Are Wegovy pills as effective as injections?

Are Wegovy Pills as Effective as Injections for Weight Loss

When we put the numbers side by side, Wegovy pills and injections yield similar weight-loss outcomes. In the main clinical trials:

Both treatments helped patients lose roughly 3-4 times more weight than diet/exercise alone (placebo). For context, placebo patients typically lost about 2-3% of weight in these trials, reflecting the effect of counseling and lifestyle changes alone. So the drug effect is about 11-12 percentage points more than placebo. Importantly, that extra loss is nearly identical for the pill and shot.

Data presented at Obesity Week 2025 also showed that once-daily 25 mg Wegovy tablet and once-weekly 2.4 mg Wegovy injection showed comparable results across body weight outcomes, cardiometabolic markers, and quality of life measures, based on an indirect comparison of the OASIS 4 and STEP 1 phase 3 trials.

In absolute terms, a patient on Wegovy injection might lose an extra 15 kg over a year, while on the pill, the loss might be around 14 kg. That difference, which is about 1 kg on average, is not statistically significant in the trials, and different studies had slightly different conditions. The important takeaway is that both forms produce strong, sustained weight loss.

The differences between 14.9 and 13.6 are within the margin of error. In fact, the pill produced up to 16.6% weight loss among participants with perfect adherence, essentially matching what the injection achieved in some studies. In short, for patients who take the Wegovy pill consistently, the overall results are nearly the same.

One reason for this similar outcome is that the active drug is the same. Once semaglutide is in the bloodstream, it acts in the same way whether it arrived via a shot or a swallowed pill. Thus, under real-world conditions, assuming good adherence, we expect the weight loss to be comparable, as the studies show.

Side effects and safety considerations

Both Wegovy injections and Wegovy pills have the same kinds of side effects, since they contain the same medication. The most common side effects are gastrointestinal:

    • Nausea
    • Vomiting
    • Diarrhea
    • Constipation

These occur because GLP-1 slows digestion. In studies, roughly 70-75% of people on semaglutide experienced some nausea or other mild stomach upset.

For instance, in the OASIS 4 trial, 74% of pill users reported GI side effects compared to 42% on placebo. Similarly, in STEP 1 (injection), nausea and diarrhea were the most common issues.

These symptoms are mild to moderate and often decrease over time as the body adjusts. A small percentage of patients (around 5%) may stop the drug early because of side effects, but the vast majority can continue with proper dose adjustments.

Because the injection can also cause local site reactions like redness or itching, those particular effects occur only with the injection. Conversely, the pill has to be swallowed and can upset the stomach, which is more of an issue with the oral form. But overall, the safety profiles are very similar.

Serious side effects are rare with both forms. Both have warnings about pancreatitis and rare thyroid tumors, so patients are advised to discuss any history of pancreas or thyroid disease with their doctor before using Wegovy. Aside from that, common precautions like not using it during pregnancy apply to both forms equally.

In sum, using either the pill or the injection carries the same risks and safety considerations, with the main differences being the mode of administration rather than the effect in the body.

Other differences between the Wegovy pill and the injection

Although the weight-loss efficacy is similar, there are some differences between Wegovy in pill form and in injection form. These differences can affect what might be easier or more convenient for you.

Administration

Wegovy injections are given once weekly via a prefilled pen. Patients typically self-inject into the abdomen, thigh, or upper arm. The dosing is started low and increased slowly (titrated) to reduce side effects. Typically, 0.25 mg in week 1, and up to 2.4 mg by week 17.

The Wegovy pill, by contrast, is taken every day. It also starts at a low dose and steps up each month. Typically, 1.5 mg daily for a month, then 4 mg, 9 mg, to 25 mg. In practice, this means someone on the shot only handles it 4 times a month, while someone on the pill must remember a daily morning routine.

Absorption

The way the medicine enters the body differs. With an injection, most of the dose goes into the bloodstream. This makes its absorption very reliable. With the oral pill, approximately 1% to 2% of the swallowed dose reaches the blood.

To get enough of the drug into the body, the pill must be taken every day on an empty stomach and with very little water. Specifically, after taking the Wegovy pill, you must wait at least 30 minutes before eating, drinking anything other than water, or taking other medications.

These strict conditions help maximize the tiny fraction that is absorbed. If someone forgets these rules, like eating too soon, the pill may not work as well. The injection has no such timing rules, so you can inject at any time of day, with or without meals.

Storage

Wegovy injections require refrigeration to stay potent, although unused pens can be kept at room temperature for up to 28 days once opened. On the other hand, the Wegovy pills do not need refrigeration and can be kept at room temperature, but must remain in their original bottle to protect them from moisture.

Flexibility and scheduling

With an injection, you choose one day of the week (say every Monday) and stick to it. You can do the shot in the morning or evening, before or after meals, whatever fits your schedule.

The pill, however, locks you into a morning routine. You have to take it first thing in the morning with a small glass of water and then wait at least 30 minutes before breakfast. Some people find this a bit inconvenient, especially if they tend to sleep in or have busy mornings.

On the other hand, if you are fine with a structured morning, the pill can be quite easy once it’s part of your habit.

Needles vs no needles

Some patients have a strong dislike of needles. For them, an oral pill is much more appealing. Having a daily pill means no self-injections or disposal of sharps. Others may not mind a once-a-week shot, especially since it quickly becomes routine.

Additional approvals

Currently, Wegovy injections are approved for more groups and uses than the pill. The shot is approved for weight loss in adolescents (12 years and older) with obesity, whereas the pill is only approved for adults. The injection is also approved for certain liver conditions (MASH), whereas the pill is not yet approved for use.

This may change in the future, but it is a factor if you fall into those categories.

Cost and availability

Both forms of Wegovy are brand-name prescription drugs made by Novo Nordisk. As of early 2026, Wegovy injections have been on the market longer and are covered by many insurance plans, with co-pays or savings cards. The Wegovy pills were approved in late 2025, and Novo Nordisk has launched programs to make them accessible.

The list price for Wegovy is high, often over $1000 per month, but patient assistance programs and savings cards can lower the out-of-pocket cost substantially. For example, Novo Nordisk offers a savings program that can reduce co-pays to as little as $25 per month for qualified patients.

Insurance coverage may differ between the two. Doctors and patients often rely on specialty pharmacies or telemedicine services that handle GLP-1 drugs. Some online clinics and insurers may prefer one form over the other for formulary or cost reasons.

It’s advisable for patients to check with their healthcare provider and insurer about coverage for the Wegovy pill versus injection. That said, as demand for GLP-1 drugs has surged, many programs are available to help reduce the cost barrier.

Wegovy Pens

Starting from $599

Ready to Buy Wegovy Online?

Choose Pharma Giant for affordable medications and take control of your health with reliable, cost-effective options today!

SAVE 10% with coupon code:

Bottom line

The new Wegovy pill appears to be as effective for weight loss as the Wegovy injection, based on clinical evidence. Both deliver the same medication (semaglutide) and have achieved very similar results in trials. In practice, choosing between the pill and the shot will hinge more on lifestyle factors and personal preference than on effectiveness.

In fact, experts say that the efficacy is comparable when patients stick to the treatment. Both treatments have the same side effects, and both require commitment to diet and exercise for the best results.

For someone worried about needles, the oral Wegovy pill is an exciting development that gives nearly the same weight loss benefit. For someone who might forget a daily pill or prefers weekly dosing, the established Wegovy shot remains an excellent option with proven long-term results.

As with any medication, you should consult with your doctor to decide which form of Wegovy is right for you.

Related Articles

Frequently Asked Questions

The Wegovy pill, which contains oral semaglutide, has shown double-digit average weight loss in clinical trials when taken daily alongside diet and activity changes. In studies, many adults lost around 10-15% of their starting body weight over about 68 weeks. Results vary based on dose, adherence, and lifestyle factors. It is generally less potent than the highest-dose injection but still clinically effective for many people.

Oral semaglutide must be taken on an empty stomach with a small amount of water, which can be inconvenient. It may cause more stomach-related side effects early on, such as nausea or bloating. Absorption is lower and more variable than with injections. Missing doses can also reduce effectiveness more quickly than with weekly shots.

For many people, losing 20 pounds with Wegovy can take around 4 to 6 months, though timelines differ. Weight loss is usually gradual, especially during the dose-escalation phase. Factors like starting weight, dose, diet, and physical activity strongly affect results. Faster loss is not guaranteed and is not the goal for everyone.

Losing 30 pounds in 3 months is possible for some individuals, but it is not typical. Most people experience steadier weight loss over several months rather than rapid drops. Very fast loss can increase side effect risk and may not be sustainable. Doctors usually focus on safe, consistent progress instead of aggressive timelines.

Yes. Oral Wegovy has received approval from the US Food and Drug Administration for chronic weight management in adults who meet specific criteria. It uses oral semaglutide at higher doses than diabetes-only tablets. Approval is based on large phase 3 clinical trials. Prescribing still depends on medical eligibility and insurance coverage.

Weight loss tends to improve when Wegovy is combined with a calorie-controlled diet, adequate protein intake, and regular physical activity. Taking the medication exactly as prescribed is important, especially for oral dosing. Strength training can help preserve muscle while losing fat. Skipping meals or extreme dieting is not recommended.

Overeating on Wegovy often leads to discomfort such as nausea, heartburn, or stomach pain. Some people may feel overly full or even vomit. Repeated overeating can slow weight loss and worsen side effects. Wegovy works best when portion sizes are reduced naturally.

The list price of the Wegovy pill is similar to the injection and is typically over $1,000 per month without insurance. Actual costs depend on coverage, pharmacy pricing, and savings programs. Some insurance plans may not yet cover the oral version. Out-of-pocket prices can vary widely.

Neither form is universally better. Injections generally lead to greater average weight loss because absorption is more consistent. Pills appeal to people who prefer avoiding needles and are willing to follow strict dosing rules. The best option depends on tolerance, lifestyle, and medical advice.

Yes. Wegovy contains higher doses of semaglutide than Ozempic and is specifically approved for weight loss. Ozempic is primarily approved for type 2 diabetes, though weight loss can occur. The higher target dose is why Wegovy typically leads to greater average weight reduction.

Sources

Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/nejmoa2032183

Wharton, S., Lingvay, I., Bogdanski, P., Vale, R. D. D., Jacob, S., Karlsson, T., Shaji, C., Rubino, D., & Garvey, W. T. (2025). Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine, 393(11), 1077–1087. https://doi.org/10.1056/nejmoa2500969

Wegovy in a pill? Massive weight loss results revealed. (2025, November 25). ScienceDaily. https://www.sciencedaily.com/releases/2025/11/251106003913.htm

Smith I, Ivkovic M, Plotkin M et al. Oral vs. injectable semaglutide: An indirect treatment comparison of weight loss outcomes. Poster presentation presented at ObesityWeek® 2025; 04–07 November 2025; Atlanta, Georgia. https://sciencehub.novonordisk.com/congresses/ow2025/plotkin.html